Camilla Normand

980 total citations
25 papers, 624 citations indexed

About

Camilla Normand is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Surgery. According to data from OpenAlex, Camilla Normand has authored 25 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Camilla Normand's work include Cardiac pacing and defibrillation studies (20 papers), Cardiac Arrhythmias and Treatments (15 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Camilla Normand is often cited by papers focused on Cardiac pacing and defibrillation studies (20 papers), Cardiac Arrhythmias and Treatments (15 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Camilla Normand collaborates with scholars based in Norway, Sweden and Germany. Camilla Normand's co-authors include Peter J. Edmonds, Y Saunders, J R Ross, Karen Broadley, David Wonderling, Kenneth Dickstein, Cecilia Linde, Jagmeet P. Singh, Thomas J. Povsic and David M. Kaye and has published in prestigious journals such as The Lancet, Heart and Health Technology Assessment.

In The Last Decade

Camilla Normand

20 papers receiving 610 citations

Peers

Camilla Normand
Celeste McCracken United Kingdom
Shikai Yu China
Christine Morrell United Kingdom
Jonathan Aning United Kingdom
Jessica M. Peña United States
Anja Velghe Belgium
Clara Fitzgerald United States
Yunji Hwang South Korea
Steven Kelly United Kingdom
Eleni Frangou United Kingdom
Celeste McCracken United Kingdom
Camilla Normand
Citations per year, relative to Camilla Normand Camilla Normand (= 1×) peers Celeste McCracken

Countries citing papers authored by Camilla Normand

Since Specialization
Citations

This map shows the geographic impact of Camilla Normand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilla Normand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilla Normand more than expected).

Fields of papers citing papers by Camilla Normand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camilla Normand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilla Normand. The network helps show where Camilla Normand may publish in the future.

Co-authorship network of co-authors of Camilla Normand

This figure shows the co-authorship network connecting the top 25 collaborators of Camilla Normand. A scholar is included among the top collaborators of Camilla Normand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilla Normand. Camilla Normand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tokodi, Márton, Annamária Kosztin, Attila Kovács, et al.. (2024). Machine learning-based prediction of 1-year all-cause mortality in patients undergoing CRT implantation: validation of the SEMMELWEIS-CRT score in the European CRT Survey I dataset. European Heart Journal - Digital Health. 5(5). 563–571.
2.
Linde, Cecilia, Lina Benson, Tonje Thorvaldsen, et al.. (2023). What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II. European Heart Journal - Quality of Care and Clinical Outcomes. 9(8). 741–748. 6 indexed citations
3.
4.
Normand, Camilla, Cecilia Linde, Carina Blomström‐Lundqvist, et al.. (2020). Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II. EP Europace. 22(6). 932–938. 8 indexed citations
5.
Normand, Camilla, David M. Kaye, Thomas J. Povsic, & Kenneth Dickstein. (2019). Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology. The Lancet. 393(10175). 1045–1055. 48 indexed citations
6.
Auricchio, Angelo, Maurizio Gasparini, Cecilia Linde, et al.. (2019). Sex-Related Procedural Aspects and Complications in CRT Survey II. JACC. Clinical electrophysiology. 5(9). 1048–1058. 9 indexed citations
7.
Tajstra, Mateusz, Elżbieta Gadula‐Gacek, Dariusz Wojciechowski, et al.. (2019). Cardiac resynchronization in Poland – comparable procedural routines? Insights from CRT Survey II. Advances in Interventional Cardiology. 15(4). 477–484. 2 indexed citations
8.
Israel, Carsten W., Cecilia Linde, Camilla Normand, et al.. (2019). Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II. Clinical Research in Cardiology. 109(7). 832–844. 3 indexed citations
9.
Normand, Camilla, Cecilia Linde, Nigussie Bogale, et al.. (2019). Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?—findings from the ESC CRT Survey II. EP Europace. 21(6). 918–927. 9 indexed citations
10.
Galand, Vincent, Cecilia Linde, Nicolas Lellouche, et al.. (2019). The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France. Archives of cardiovascular diseases. 112(11). 713–722.
11.
Sterliński, Maciej, Mateusz Tajstra, Krystian Josiak, et al.. (2018). Do we differ in terms of indications and demographics in cardiac resynchronisation recipients in Poland? Insights from the European CRT Survey II Registry. Kardiologia Polska. 77(1). 40–46. 4 indexed citations
12.
Linde, Cecilia, Camilla Normand, Nigussie Bogale, et al.. (2018). Upgrades from a Previous Device Compared to De Novo Cardiac Resynchronization Therapy in the European Society of Cardiology CRT Survey II. European Journal of Heart Failure. 20(10). 1457–1468. 33 indexed citations
13.
Normand, Camilla, Cecilia Linde, Jagmeet P. Singh, & Kenneth Dickstein. (2018). Indications for Cardiac Resynchronization Therapy. JACC Heart Failure. 6(4). 308–316. 53 indexed citations
14.
Burri, Haran, Alexander Breitenstein, Peter Ammann, et al.. (2018). Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe and in Switzerland. Swiss Medical Weekly. 148(3334). w14643–w14643.
15.
Brusich, Sandro, Nikola Pavlović, Ante Anić, et al.. (2018). Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter Registry. Cardiology Research and Practice. 2018. 1–8. 1 indexed citations
16.
Dickstein, Kenneth, Camilla Normand, Stefan D. Anker, et al.. (2014). European Cardiac Resynchronization Therapy Survey II: rationale and design. EP Europace. 17(1). 137–141. 15 indexed citations
17.
Levesque, Nadja, et al.. (2008). Health Management Program: Factors Influencing Completion of Therapy with High-Dose Interferon Alfa-2b for High-Risk Melanoma. Current Oncology. 15(1). 36–41. 15 indexed citations
18.
Levesque, Nadja, et al.. (2006). Benefits of hydration in patients receiving intron A therapy for high-risk melanoma: a nursing support program to minimize drug-related side effects. Melanoma Research. 16(Supplement 1). S38–S39. 2 indexed citations
19.
Ross, J R, Y Saunders, Peter J. Edmonds, et al.. (2004). A systematic review of the role of bisphosphonates in metastatic disease. Health Technology Assessment. 8(4). 1–176. 387 indexed citations
20.
Bakhai, Ameet, J Collinson, Camilla Normand, et al.. (2001). Health economic burden of non-ST-segment elevation acute coronary syndromes in Europe. Results from PRAIS-UK. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celeste McCracken Breakdown of academic impact, for papers by Shikai Yu Breakdown of academic impact, for papers by Christine Morrell Breakdown of academic impact, for papers by Jonathan Aning Breakdown of academic impact, for papers by Jessica M. Peña Breakdown of academic impact, for papers by Anja Velghe Breakdown of academic impact, for papers by Clara Fitzgerald Breakdown of academic impact, for papers by Yunji Hwang Breakdown of academic impact, for papers by Steven Kelly Breakdown of academic impact, for papers by Eleni Frangou
Rankless by CCL
2026